TrialArthritis research & therapy2019

Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort.

Nan Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.